A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing

P J Davis1, J Galinkin, F X McGowan

  • 1Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213-2583, USA. davispj@anes.upmc.edu

Anesthesia and Analgesia
|December 1, 2001
PubMed

Insights

Remifentanil anesthesia is comparable to halothane for infant pyloromyotomy, showing similar hemodynamic stability and recovery. However, remifentanil may reduce the risk of postoperative apnea in infants under two months old.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery

Background:

  • Pyloric stenosis can lead to hemodynamic instability and postoperative apnea in infants.
  • Evaluating anesthetic techniques is crucial for optimizing outcomes in pediatric surgical patients.

Purpose of the Study:

  • To compare the hemodynamic response and recovery profile of remifentanil versus halothane in infants undergoing pyloromyotomy.
  • To assess the incidence of postoperative apnea associated with each anesthetic agent.

Main Methods:

  • A multicenter, randomized controlled trial comparing remifentanil and halothane anesthesia in infants undergoing pyloromyotomy.
  • Patients received either remifentanil or halothane as maintenance anesthesia after initial induction.
  • Hemodynamic parameters, pneumograms, and postanesthesia care unit (PACU) recovery data were collected and analyzed.

Main Results:

  • No significant differences were observed in intraoperative hemodynamics, extubation times, PACU discharge times, pain medication requirements, or adverse events between the remifentanil and halothane groups.
  • No patient receiving remifentanil with a normal preoperative pneumogram developed an abnormal postoperative pneumogram.
  • Three patients receiving halothane with normal preoperative pneumograms had abnormal postoperative pneumograms.

Conclusions:

  • Remifentanil anesthesia is a safe and effective alternative to halothane for pyloromyotomy in infants.
  • Ultra-short-acting opioids like remifentanil may be particularly beneficial for infants under two months old when early tracheal extubation is planned, potentially reducing the risk of postoperative apnea.
Abstract

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...